Lv6
2848 积分 2022-06-17 加入
Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia
2天前
已完结
Dosing and Switching Strategies for Paliperidone Palmitate
3天前
已完结
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
3天前
已完结
A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
3天前
已完结
The development of paliperidone nanocrystals for the treatment of schizophrenia
4天前
已完结
In vitro and in vivo characterization of Invega Sustenna® (paliperidone palmitate long-acting injectable suspension)
10天前
已完结
Paliperidone Extended-Release Tablets for Prevention of Symptom Recurrence in Patients With Schizophrenia
10天前
已完结
Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study
11天前
已完结
Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder
11天前
已完结
Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol
11天前
已完结
皖公网安备34019202002308
